Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Recurrent Colorectal Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00033748
What this trial is testing

Vaccine Therapy in Treating Patients With Colorectal Cancer Metastatic to the Liver

Who this might be right for
Colorectal CancerMetastatic Cancer
Alliance for Clinical Trials in Oncology 56
Not applicableStudy completedNCT05475301
What this trial is testing

Incidence, Risk Factor, Treatment and Overall Survival of Locally Recurrent Rectal Cancer

Who this might be right for
Rectal NeoplasmsNeoplasm Recurrence, Local
Radboud University Medical Center 1,431
Large-scale testing (Phase 3)Study completedNCT00002716
What this trial is testing

Combination Chemotherapy in Treating Patients With Liver Metastases From Colorectal Cancer

Who this might be right for
Colorectal CancerMetastatic Cancer
Alliance for Clinical Trials in Oncology 135
Testing effectiveness (Phase 2)WithdrawnNCT00571740
What this trial is testing

Cetuximab and Bevacizumab as First-Line Therapy Followed By Combination Chemotherapy and Bevacizumab With or Without Cetuximab as Second-Line Therapy in Treating Patients With Stage IV Colorectal Cancer

Who this might be right for
Colorectal Cancer
Alliance for Clinical Trials in Oncology
Testing effectiveness (Phase 2)Study completedNCT00016978
What this trial is testing

Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer Previously Treated With Irinotecan

Who this might be right for
Colorectal Cancer
National Cancer Institute (NCI) 40
Not applicableStudy completedNCT05495308
What this trial is testing

"Oncologic Results and Risk Factors for Recurrence in Patients With Locally Advanced Rectal Cancer and Pathologic Complete Response After Neoadjuvant Treatment. Results From an Observational Retrospective Multicenter Long-term Follow-up Study".

Who this might be right for
Rectal Cancer, AdenocarcinomaRectal Cancer Stage IIRectal Cancer Stage III+2 more
Hospital San Carlos, Madrid 4
Not applicableEnded earlyNCT01271959
What this trial is testing

ChemoFx® Chemoresponse Assay in Solid Tumors - ChemoFx® Registry Study

Who this might be right for
Solid Organ Tumors
Precision Therapeutics 167
Not applicableStudy completedNCT00280761
What this trial is testing

Biomarkers in Patients With Rectal Cancer Undergoing Chemotherapy and Radiation Therapy

Who this might be right for
Colorectal Cancer
UNC Lineberger Comprehensive Cancer Center 47
Testing effectiveness (Phase 2)Ended earlyNCT00766142
What this trial is testing

Chemotherapy and Cetuximab in Patients Undergoing Surgery for Peritoneal Carcinomatosis From Colorectal Cancer

Who this might be right for
Colorectal CancerPrimary Peritoneal Cavity Cancer
Institut Bergonié 18
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07405736
What this trial is testing

Lubiprostone Combined With Maintenance Therapy for Prevention of Postoperative Recurrence in Peritoneal Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer MetastaticPeritoneal (Metastatic) CancerPeritoneal Metastasis+2 more
Sun Yat-sen University 124
Not applicableLooking for participantsNCT04907643
What this trial is testing

Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes

Who this might be right for
Cancer PainVisceral PainGastrointestinal Neoplasms+76 more
Cedars-Sinai Medical Center 360
Not applicableStudy completedNCT00410618
What this trial is testing

Neurological Effects of Chemotherapy and Radiation Therapy in Patients With Colon Cancer

Who this might be right for
Cognitive/Functional EffectsColorectal CancerLong-term Effects Secondary to Cancer Therapy in Adults
University of Arizona 42
Testing effectiveness (Phase 2)Study completedNCT02399813
What this trial is testing

Axalimogene Filolisbac (ADXS11-001) in Participants With Carcinoma of the Anorectal Canal

Who this might be right for
Anal CancerRectal Cancer
Advaxis, Inc. 36
Testing effectiveness (Phase 2)Active Not RecruitingNCT05990543
What this trial is testing

Combination of Nelmastobart and Capecitabine Therapy in Metastatic Colorectal Cancer

Who this might be right for
Recurrent or Metastatic Colorectal Cancer
Korea University Anam Hospital 59
Testing effectiveness (Phase 2)Study completedNCT00003995
What this trial is testing

Monoclonal Antibody Plus Chemotherapy in Treating Patients With Advanced Colorectal Cancer That Overexpresses HER2

Who this might be right for
Colorectal Cancer
National Cancer Institute (NCI) 32
Testing effectiveness (Phase 2)Study completedNCT02713373
What this trial is testing

Cetuximab and Pembrolizumab in Treating Patients With Colorectal Cancer That is Metastatic or Cannot Be Removed by Surgery

Who this might be right for
Recurrent Colorectal CarcinomaStage IVA Colorectal CancerStage IVB Colorectal Cancer
Roswell Park Cancer Institute 45
Early research (Phase 1)Ended earlyNCT02313012
What this trial is testing

Safety and PK Study of CC-90003 in Relapsed/Refractory Solid Tumors

Who this might be right for
Neoplasm Metastasis
Celgene 19
Early research (Phase 1)Study completedNCT00132522
What this trial is testing

EMD 273066 in Patients With Recurrent EpCAM Positive Ovarian, Prostate, Colorectal or Non-small Cell Lung Cancers When First Given Cyclophosphamide

Who this might be right for
Ovarian CancerColorectal CancerCarcinoma, Non-small-cell Lung+1 more
EMD Serono 45
Early research (Phase 1)Study completedNCT00118261
What this trial is testing

Erlotinib, Modified FOLFOX6, and Bevacizumab as First-Line Therapy Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Case Comprehensive Cancer Center 17
Not applicableStudy completedNCT00477919
What this trial is testing

E-MOSAIC Electronic Tool to Monitor Symptoms

Who this might be right for
Cancer
Swiss Cancer Institute 264
Next Page